Friday 22

Friday 22

by

Didier Berthelot
-
Janssen, Pharmaceutical Companies
Targeted protein degradation as a new modality in drug discovery: expanding the medicinal chemist toolbox

Eva Galán
-
Centro Regional de Investigaciones Biomédicas UCLM
Targeted protein degradation as a strategy for breast cancer therapy

Coffee Break
-

Pablo Menendez
-
Adoptive Cellular Immunotherapy based on Chimeric Antigen Receptors

Laura Soucek
-
A first-in-class mini-protein against MYC as a novel cancer therapy

Closing Remarks
-

Farewell Cocktail
-

Safe trip back home
-